Atlas FDA

OPP

7 FDA 510(k) clearances · Product code

112 daysmedian time to decision
279 days90th percentile
7clearances measured

FDA profile

Official device name
Pump, Infusion, Insulin Bolus
Device class
Class II (moderate risk)
Regulation
21 CFR 880.5725
Medical specialty
General Hospital
FDA definition
The device is adhered to the body for several days for the purpose of periodically infusing an insulin bolus.
Adverse events (MAUDE)
2015: 22
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
CeQur Simplicity™ On-Demand Insulin Delivery System (K252757)Cequr SA2026-04-10
CeQur Simplicity™ On-Demand Insulin Delivery System (K243273)Cequr SA2024-11-13
CeQur Simplicity™ On-Demand Insulin Delivery System (K233447)Cequr SA2024-01-18
OneTouch Via On-Demand Insulin Delivery System (K163357)Lifescan Europe, A Division of Cilag GmbH2017-06-07
FINESSE PERSONAL INSULIN DELIVERY PATCH (K111924)Calibra Medical, Inc.2012-04-10
FINESSE PERSONAL INSULIN DELIVERY PATCH, MODEL FG 2000 (K100947)Calibra Medical, Inc.2010-06-28
FINESSE PERSONAL INSULIN DELIVERY PATCH, MODEL FG-2000 (K093065)Calibra Medical, Inc.2010-01-20

Track OPP automatically

Every clearance here is in the API, with alerts when new ones post.